by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Apothecary Pharma, LLC Warning Letter Details

Warning Letter

Apothecary Pharma, LLC

Recipient Title President and Chief Pharmacy Officer, Apothecary Pharma, LLC, 1913 Evans Road Cary , NC 27513-2041 United States

Issue DateDecember 01, 2025

FEI NumberN/A

Violations9

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Compounding Pharmacy/Adulterated Drug Products

Apothecary Pharma, LLC FDA Warning Letter, December 1, 2025